![Wesley Kaupinen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Wesley Kaupinen
Gründer bei
Palvella Therapeutics, Inc.
Vermögen: 246 Mio $ am 30.06.2026
Profil
Wesley H.
Kaupinen is the founder of Palvella Therapeutics, Inc., founded in 2015, serving as President, Chief Executive Officer & Director.
Mr. Kaupinen is also the founder of Palvella Therapeutics, Inc., founded in 2024, serving as President, Chief Executive Officer & Director.
Former jobs include Director at Intact Vascular, Inc., Director at TELA Bio, Inc., Partner at Apax Partners, Inc., VP-Corporate Development & Commercialization at Insmed, Inc., Senior Associate at Quaker Partners Management LP from 2009 to 2011, Principal at Robertson Stephens, Inc., and Principal at Synthes Spine Co. Education includes undergraduate studies at the University of Virginia and an MBA from The Wharton School of the University of Pennsylvania.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
11,21 % | 05.02.2026 | 1.607.228 ( 11,21 % ) | 246 Mio $ | 30.06.2026 |
Aktive Positionen von Wesley Kaupinen
| Unternehmen | Position | Beginn |
|---|---|---|
Palvella Therapeutics, Inc.
 Palvella Therapeutics, Inc. BiotechnologyHealth Technology Engages in developing new therapeutic agents for diseases suffered by patients that lack any treatment choices | Gründer | 01.01.2015 |
Ehemalige bekannte Positionen von Wesley Kaupinen
| Unternehmen | Position | Ende |
|---|---|---|
Apax Partners, Inc.
 Apax Partners, Inc. Investment ManagersFinance Apax Partners focuses exclusively on long-term investments in growth companies. The firm invests globally in the following sectors: (1) financial and business services (2) healthcare (3) media (4) retail and consumer and (5) technology and telecommunications. They target large companies with strong, established market positions and the potential to expand. Apax Partners' investment strategy is to grow businesses by acting as a catalyst for change and to employ clear processes to maximize the value of their portfolio. | Private Equity Investor | 31.12.2005 |
| TELA BIO, INC. | Direktor/Vorstandsmitglied | - |
| INSMED INCORPORATED | Corporate Officer/Principal | - |
Intact Vascular, Inc.
 Intact Vascular, Inc. Medical SpecialtiesHealth Technology Develops medical devices for minimally invasive peripheral vascular procedures | Direktor/Vorstandsmitglied | - |
Robertson Stephens, Inc.
 Robertson Stephens, Inc. Investment Banks/BrokersFinance Brokerage | Corporate Officer/Principal | - |
Ausbildung von Wesley Kaupinen
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
14
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
Apax Partners, Inc.
Apax Partners, Inc. Investment ManagersFinance Apax Partners focuses exclusively on long-term investments in growth companies. The firm invests globally in the following sectors: (1) financial and business services (2) healthcare (3) media (4) retail and consumer and (5) technology and telecommunications. They target large companies with strong, established market positions and the potential to expand. Apax Partners' investment strategy is to grow businesses by acting as a catalyst for change and to employ clear processes to maximize the value of their portfolio. | Finance |
Insmed, Inc.
 Insmed, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases | Health Technology |
Intact Vascular, Inc.
Intact Vascular, Inc. Medical SpecialtiesHealth Technology Develops medical devices for minimally invasive peripheral vascular procedures | Health Technology |
TELA Bio, Inc.
 TELA Bio, Inc. Medical SpecialtiesHealth Technology Operates as medical technology company, which designs, develops and markets tissue reinforcement materials to address unmet needs in soft tissue reconstruction | Health Technology |
University of Virginia
 University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Quaker Partners Management LP
 Quaker Partners Management LP Investment ManagersFinance Quaker Partners Management invests in healthcare companies located in the United States primarily in East Coast. The firm targets companies operating in the fields of biopharmaceuticals, medical devices, human diagnostics, specialty pharmaceuticals and healthcare services. It participates in seed and early stage capital requirements. | Finance |
Robertson Stephens, Inc.
Robertson Stephens, Inc. Investment Banks/BrokersFinance Brokerage | Finance |
Synthes Spine Co.
 Synthes Spine Co. Medical SpecialtiesHealth Technology Offers implants and instruments for the treatment of fractures | Health Technology |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Palvella Therapeutics, Inc.
Palvella Therapeutics, Inc. BiotechnologyHealth Technology Engages in developing new therapeutic agents for diseases suffered by patients that lack any treatment choices | Health Technology |
Wählen Sie MarketScreener 
